BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 23898169)

  • 21. Interactions of STAT5b-RARalpha, a novel acute promyelocytic leukemia fusion protein, with retinoic acid receptor and STAT3 signaling pathways.
    Dong S; Tweardy DJ
    Blood; 2002 Apr; 99(8):2637-46. PubMed ID: 11929748
    [TBL] [Abstract][Full Text] [Related]  

  • 22. C/EBPα is indispensable for PML/RARα-mediated suppression of long non-coding RNA NEAT1 in acute promyelocytic leukemia cells.
    Tang D; Hu P; Zhu D; Luo Y; Chen M; Zhang G; Wang Y
    Aging (Albany NY); 2021 Apr; 13(9):13179-13194. PubMed ID: 33901013
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The tumor suppressor gene DAPK2 is induced by the myeloid transcription factors PU.1 and C/EBPα during granulocytic differentiation but repressed by PML-RARα in APL.
    Humbert M; Federzoni EA; Britschgi A; Schläfli AM; Valk PJ; Kaufmann T; Haferlach T; Behre G; Simon HU; Torbett BE; Fey MF; Tschan MP
    J Leukoc Biol; 2014 Jan; 95(1):83-93. PubMed ID: 24038216
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Characterisation of genome-wide PLZF/RARA target genes.
    Spicuglia S; Vincent-Fabert C; Benoukraf T; Tibéri G; Saurin AJ; Zacarias-Cabeza J; Grimwade D; Mills K; Calmels B; Bertucci F; Sieweke M; Ferrier P; Duprez E
    PLoS One; 2011; 6(9):e24176. PubMed ID: 21949697
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Distinct interactions of PML-RARalpha and PLZF-RARalpha with co-repressors determine differential responses to RA in APL.
    He LZ; Guidez F; Tribioli C; Peruzzi D; Ruthardt M; Zelent A; Pandolfi PP
    Nat Genet; 1998 Feb; 18(2):126-35. PubMed ID: 9462740
    [TBL] [Abstract][Full Text] [Related]  

  • 26. AML-1/ETO fusion protein is a dominant negative inhibitor of transcriptional repression by the promyelocytic leukemia zinc finger protein.
    Melnick A; Carlile GW; McConnell MJ; Polinger A; Hiebert SW; Licht JD
    Blood; 2000 Dec; 96(12):3939-47. PubMed ID: 11090081
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Components of the SMRT corepressor complex exhibit distinctive interactions with the POZ domain oncoproteins PLZF, PLZF-RARalpha, and BCL-6.
    Wong CW; Privalsky ML
    J Biol Chem; 1998 Oct; 273(42):27695-702. PubMed ID: 9765306
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sequence-specific DNA binding and transcriptional regulation by the promyelocytic leukemia zinc finger protein.
    Li JY; English MA; Ball HJ; Yeyati PL; Waxman S; Licht JD
    J Biol Chem; 1997 Sep; 272(36):22447-55. PubMed ID: 9278395
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The RAR alpha-PLZF chimera associated with Acute Promyelocytic Leukemia has retained a sequence-specific DNA-binding domain.
    Sitterlin D; Tiollais P; Transy C
    Oncogene; 1997 Mar; 14(9):1067-74. PubMed ID: 9070655
    [TBL] [Abstract][Full Text] [Related]  

  • 30. AML-associated translocation products block vitamin D(3)-induced differentiation by sequestering the vitamin D(3) receptor.
    Puccetti E; Obradovic D; Beissert T; Bianchini A; Washburn B; Chiaradonna F; Boehrer S; Hoelzer D; Ottmann OG; Pelicci PG; Nervi C; Ruthardt M
    Cancer Res; 2002 Dec; 62(23):7050-8. PubMed ID: 12460926
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Acute promyelocytic leukemia and variant fusion proteins: PLZF-RARα fusion protein at a glance.
    Hussain L; Maimaitiyiming Y; Islam K; Naranmandura H
    Semin Oncol; 2019 Apr; 46(2):133-144. PubMed ID: 31126665
    [TBL] [Abstract][Full Text] [Related]  

  • 32. PIC-1/SUMO-1-modified PML-retinoic acid receptor alpha mediates arsenic trioxide-induced apoptosis in acute promyelocytic leukemia.
    Sternsdorf T; Puccetti E; Jensen K; Hoelzer D; Will H; Ottmann OG; Ruthardt M
    Mol Cell Biol; 1999 Jul; 19(7):5170-8. PubMed ID: 10373566
    [TBL] [Abstract][Full Text] [Related]  

  • 33. C/EBPα and PU.1 are involved in distinct differentiation responses of acute promyelocytic leukemia HL-60 and NB4 cells via chromatin remodeling.
    Savickiene J; Treigyte G; Vistartaite G; Tunaitis V; Magnusson KE; Navakauskiene R
    Differentiation; 2011 Jan; 81(1):57-67. PubMed ID: 20864248
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Study of dominant negative effect of the PLZF-RARalpha against the wild-type RARalpha in acute promyelocytic leukemia].
    Dong S; Zhu J; Kuang S; Qiu J; Wang Z; Chen S; Chen L
    Zhonghua Xue Ye Xue Za Zhi; 1997 Jan; 18(1):8-12. PubMed ID: 15622742
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Overexpression of wild-type retinoic acid receptor alpha (RARalpha) recapitulates retinoic acid-sensitive transformation of primary myeloid progenitors by acute promyelocytic leukemia RARalpha-fusion genes.
    Du C; Redner RL; Cooke MP; Lavau C
    Blood; 1999 Jul; 94(2):793-802. PubMed ID: 10397747
    [TBL] [Abstract][Full Text] [Related]  

  • 36. HDAC4 mediates transcriptional repression by the acute promyelocytic leukaemia-associated protein PLZF.
    Chauchereau A; Mathieu M; de Saintignon J; Ferreira R; Pritchard LL; Mishal Z; Dejean A; Harel-Bellan A
    Oncogene; 2004 Nov; 23(54):8777-84. PubMed ID: 15467736
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Transcriptional regulation in acute promyelocytic leukemia.
    Lin RJ; Sternsdorf T; Tini M; Evans RM
    Oncogene; 2001 Oct; 20(49):7204-15. PubMed ID: 11704848
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Deregulation of NPM and PLZF in a variant t(5;17) case of acute promyelocytic leukemia.
    Hummel JL; Wells RA; Dubé ID; Licht JD; Kamel-Reid S
    Oncogene; 1999 Jan; 18(3):633-41. PubMed ID: 9989813
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The PLZF gene of t (11;17)-associated APL.
    McConnell MJ; Licht JD
    Curr Top Microbiol Immunol; 2007; 313():31-48. PubMed ID: 17217037
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The integrity of the charged pocket in the BTB/POZ domain is essential for the phenotype induced by the leukemia-associated t(11;17) fusion protein PLZF/RARalpha.
    Puccetti E; Zheng X; Brambilla D; Seshire A; Beissert T; Boehrer S; Nürnberger H; Hoelzer D; Ottmann OG; Nervi C; Ruthardt M
    Cancer Res; 2005 Jul; 65(14):6080-8. PubMed ID: 16024608
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.